Adamed among the 10 most innovative Polish companies

About Adamed
About Adamed
Adamed in Poland
Adamed across the globe
Management Team of Adamed Pharma S.A.
Mission and values
Ethics and Compliance
Adamed for the Family
News
Adamed is a pharmaceutical and biotechnology company with almost 40 years of experience, founded on the basis of Polish scientific advances and a patent portfolio.
Products
Produkty
Prescription drugs
OTC drugs
Dietary supplements
Dermocosmetics
Medical devices
We provide patients with the highest quality medicinal products that are a response to chronic civilization diseases in several therapeutic areas.
Development and innovation
Development and innovation
Research
Development of proprietary medicines
Development of value-added medicines
Business development Startups Requests for proposals and tenders
Innovation is at the core of Adamed’s evolution. It allows us to pursue our mission by responding to the key challenges of modern medicine.
ESG
CSR
Adamed Foundation
Social programmes
Code of Ethics
Responsibility is one of our key values. It is at the core of everything we do and has earned us the trust of patients and the medical community.
Career
Career
Benefits
Development
Locations
Internships and apprenticeships
People are a priority at Adamed, and their passion and dedication has helped us grow into a successful company. Recognising the value of our staff, we are committed to providing excellent work conditions and career opportunities.
Contact

Global English

Popular searches Innovations About Adamed Business Development Adamed worldwide Researches

x

Development and innovation

29 March 2019

In an innovativeness ranking by Rzeczpospolita daily, Adamed was listed among the top 10 Polish companies.

Rzeczpospolita’s ranking was created based on data concerning expenditure on research and development (R&D) per full-time employee, expenditure structure and financing, divided into own, EU and budget spending.

Pharmaceutical innovation

The national pharmaceutical industry drives innovation in the Polish economy. National pharmaceutical and biotech companies initiate and finance research into innovative Polish drugs, in collaboration with Polish scientific centres.

At Adamed, research and development has been a key area of the company’s activity since its establishment. Adamed began its search of innovative drugs as early as 2001 and was the first Polish pharmaceutical company to do so. In 2017, outlays on the development of new pharmaceutical products accounted for 57% of total investment outlays; at that time the company spent 4.5 times more on average (as a % of investment revenues) than the entire pharmaceutical industry [1]. Adamed is working on innovative substances, as well as improving its products and therapeutic methods by using the latest technology, focused on, among others, new routes and methods of administration, new indications or combo drugs i.e. containing several active substances in one tablet.

Poland against a global background

Rzeczpospolita writes that investment by Polish companies in R&D activities increased by 13% over the last year. With respect to these types of expenditure, Poland ranks 21st among OECD countries, and in 2017 outlays on R&D amounted to only 1.03% of GDP.

In comparison, in the Czech Republic, they amount to 1.79% of GDP and in Austria – 3.15% of GDP. Global giants such as Amazon and Alphabet earmark more than 10 percent of their annual revenue on R&D work. In 2018, the record holder in this area was Amazon with more than 40% year-on-year growth and USD 22.6 billion allocated for this purpose.

[1]Comparison based on CSO data